Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes
Clinical trial NCT02317484 · COMPLETED
Trial details
- NCT number
- NCT02317484
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-11-21
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.